A device for affecting vascular blood flow and methods thereof
AssigneeNovapulse Ltd
InventorsShaul Ozeri, Gal Atarot, Shai Policker
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to an implantable device that delivers therapeutic energy to a patient. More specifically it relates to implantable ultrasonic devices adapted to affect vascular endothelium to induce at least one substance selected from Nitric Oxide, NO, and/or adenosine triphosphate (ATP) release. Furthermore, the present disclosure relates to the treatment of various medical conditions, such as pulmonary hypertension, peripheral arterial disease (PAD) and Asthma by enhancing local perfusion to specific target organs.
Claims22
1-80. (canceled)
A device adapted to be implanted adjacent to at least one vessel or tissue containing flowing blood, the device comprising:
- at least one ultrasonic transducer configured to emit ultrasonic energy toward the at least one vessel or tissue, so as to cause a physiologic effect in the at least one vessel or tissue;
- wherein the device is configured to be in communication with at least one on-skin remote controller positioned externally to the patient and configured to control the ultrasonic energy;
- and
- wherein the device is configured to be in communication with at least one sensor configured to monitor at least one physiological state of the patient.
A system comprising:
- at least one implantable device adapted to be implanted adjacent to at least one vessel or tissue containing flowing blood, the at least one implantable device comprising at least one ultrasonic transducer configured to emit ultrasonic energy toward the at least one vessel or tissue, so as to cause a physiologic effect in the at least one vessel or tissue;
- at least one on-skin remote controller configured to be positioned externally to the patient and configured to control the ultrasonic energy;
- and
- at least one sensor configured to monitor at least one physiological state of the patient;
- wherein the at least one implantable device is configured to be in communication with the at least one on-skin remote controller and with the at least one sensor.
A method of treating a patient using an implantable device adapted to be implanted adjacent to at least one vessel or tissue containing flowing blood, the method comprising:
- using at least one ultrasonic transducer of the implantable device, emitting ultrasonic energy toward the at least one vessel or tissue, so as to cause a physiologic effect in the at least one vessel or tissue;
- using at least one sensor, monitoring at least one physiological state of the patient;
- and
- using at least one on-skin remote controller, controlling at least one of an operation of the implantable device and one or more parameters of the emitted ultrasonic energy, based on data collected by the at least one sensor.
Dependencies are inferred from the claim text.